Risk taking in patients with rheumatoid arthritis: Are the risks of haemopoietic stem cell transplantation acceptable?

Rheumatology

Volumn 38, Issue 4, 1999, Pages 321-324

  Snowden, J A ^a,b   Nivison Smith, I ^a   Biggs, J C ^a   Brooks, P M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Autoimmune diseases; Bone marrow transplantation; Rheumatoid arthritis; Stem cell transplantation

Indexed keywords

ANTIRHEUMATIC AGENT;

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; DISABILITY; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; GENDER; HEMATOPOIETIC STEM CELL; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS; RISK; SCORING SYSTEM; STEM CELL TRANSPLANTATION; WORK;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; QUESTIONNAIRES; RISK ASSESSMENT; RISK-TAKING;

EID: 0032746307     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.4.321     Document Type: Article

References (18)

1. van Bekkum DW, Marmont A, Tyndall A, Vriesendorp FJ, Apatoff BJ, Rowlings PA. Severe autoimmune diseases: a new target for bone marrow transplantation. Stem Cells 1996;14:460-72.
2. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997;19:643-5.
3. Wicks I, Cooley H, Szer J. Autologous hemopoietic stem cell transplantation: a possible cure for rheumatoid arthritis? Arthritis Rheum 1997;40: 1005-11.
4. Snowden JA, Brooks PM, Biggs JC. Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol 1997;99:9-22.
5. Markenson JA. World wide trends in the socioeconomic impact and long term prognosis of rheumatoid arthritis. Semin Arthritis Rheum 1991;21(suppl. 1):4-12.
6. Wilske KR, Healey LA. The need for aggressive therapy of rheumatoid arthritis. Rheum Dis Clin North Am 1993;19:153-61.
7. Thompson MS. Willingness to pay and accept risks to cure chronic disease. Am J Public Health 1986;76:392-6.
8. O'Brien BJ, Elswood J, Calin A. Willingness to accept risk in the treatment of rheumatic disease. J Epidemiol Community Health 1990;44:249-52.
9. Bagge E, Traub M, Crotty M, Conaghan PG, Oh E, Brooks PM. Are rheumatoid arthritis patients more willing to accept non-steroidal anti-inflammatory drug treatment risks than osteoarthritis patients. Br J Rheumatol 1997;36:470-2.
10. Atkinson K, Nivison-Smith I, Hawkins T. Haemopoietic stem cell transplantation in Australia 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry. Aust NZ Med J 1997;27:408-19.
11. Chao NJ, Tierney K, Bloom JR, Long GD, Barr TA, Stallbaum BA et al. Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 1992;80:825-30.
12. Thornton JG, Lilford RJ, Johnson N. Decision analysis in medicine. Br Med J 1992;304:1099-103.
13. Pauker SG, Kassirer JP. Decision analysis. N Engl J Med 1987;316:250-8.
14. Rasker JJ, Cosh JA. Long term effects of treating rheumatoid arthritis. Baillière's Clin Rheumatol 1992;6:141-60.
15. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
16. Yellen SB, Cella DF. Someone to live for: social well-being, parenthood status, and decision making in oncology. J Clin Oncol 1995;13:1255-64.
17. Joske DJL, Ma DT, Langlands DR, Owen ET. Autologous bone marrow transplantation for rheumatoid arthritis. Lancet 1997;350:337-8.
18. Durez P, Toungouz M, Schandene L et al. Remission and immune reconstitution after T-cell depleted stem cell transplantation for rheumatoid arthritis. Lancet 1998;352:881.